Esperion Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Esperion Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Esperion Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Esperion Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $3.4M | 2.1M | 1.65 |
| 2024-06-30 | $4.5M | 2.0M | 2.22 |
| 2024-03-31 | $5.6M | 2.1M | 2.68 |
| 2023-12-31 | $5.6M | 1.9M | 2.99 |
| 2023-09-30 | $1.8M | 1.9M | 0.98 |
| 2023-06-30 | $311k | 224k | 1.39 |
| 2023-03-31 | $219k | 130k | 1.68 |
| 2022-12-31 | $2.3M | 376k | 6.23 |
| 2022-06-30 | $5.6M | 881k | 6.33 |
| 2022-03-31 | $3.5M | 754k | 4.62 |
| 2021-12-31 | $605k | 117k | 5.15 |
| 2021-03-31 | $3.5M | 125k | 28.05 |
| 2020-12-31 | $3.4M | 131k | 26.21 |
| 2020-09-30 | $5.0M | 134k | 37.46 |
| 2020-06-30 | $7.3M | 142k | 51.36 |
| 2020-03-31 | $4.3M | 136k | 32.00 |
| 2019-12-31 | $6.0M | 101k | 59.65 |
| 2019-09-30 | $5.1M | 138k | 36.66 |
| 2019-06-30 | $6.9M | 141k | 48.82 |
| 2019-03-31 | $3.3M | 81k | 40.13 |
| 2018-12-31 | $9.4M | 203k | 46.01 |
| 2018-09-30 | $3.2M | 71k | 44.37 |
| 2018-06-30 | $2.7M | 69k | 39.18 |
| 2018-03-31 | $18M | 246k | 72.34 |
| 2017-12-31 | $5.4M | 82k | 65.85 |
| 2017-06-30 | $7.8M | 169k | 46.28 |
| 2017-03-31 | $6.5M | 184k | 35.31 |
| 2016-12-31 | $2.5M | 197k | 12.52 |
| 2016-09-30 | $2.5M | 181k | 13.85 |
| 2016-06-30 | $1.9M | 142k | 13.51 |
| 2016-03-31 | $1.7M | 100k | 16.91 |
| 2015-12-31 | $2.4M | 110k | 22.26 |
| 2015-09-30 | $4.8M | 204k | 23.60 |
| 2015-03-31 | $10M | 108k | 92.58 |